Fatal hepatotoxicity associated with troglitazone

被引：55

作者：

Vella, A ^{[1
]}

de Groen, PC ^{[1
]}

Dinneen, SF ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

来源：

关键词：

D O I：

10.7326/0003-4819-129-12-199812150-00032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1080 / 1080

页数：1

共 5 条

[1] Esophagitis associated with the use of alendronate
deGroen, PC
Lubbe, DF
Hirsch, LJ
Daifotis, A
Stephenson, W
Freedholm, D
PryorTillotson, S
Seleznick, MJ
Pinkas, H
Wang, KK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1016 - 1021
[2] Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
Schwartz, S
Raskin, P
Fonseca, V
Graveline, JF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) : 861 - 866
[3] Update in endocrinology
Whitcomb, RW
[J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (10) : 871 - 871
[4] 1998, PHYSICIANS DESK REFE, P2118
[5] 1997, SCRIP, V2290, P15